169 related articles for article (PubMed ID: 28005916)
1. The TRIAGE-ProADM Score for an Early Risk Stratification of Medical Patients in the Emergency Department - Development Based on a Multi-National, Prospective, Observational Study.
Kutz A; Hausfater P; Amin D; Amin A; Canavaggio P; Sauvin G; Bernard M; Conca A; Haubitz S; Struja T; Huber A; Mueller B; Schuetz P;
PLoS One; 2016; 11(12):e0168076. PubMed ID: 28005916
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study.
Schuetz P; Hausfater P; Amin D; Amin A; Haubitz S; Faessler L; Kutz A; Conca A; Reutlinger B; Canavaggio P; Sauvin G; Bernard M; Huber A; Mueller B;
Crit Care; 2015 Oct; 19():377. PubMed ID: 26511878
[TBL] [Abstract][Full Text] [Related]
3. Combination of the National Early Warning Score (NEWS) and inflammatory biomarkers for early risk stratification in emergency department patients: results of a multinational, observational study.
Eckart A; Hauser SI; Kutz A; Haubitz S; Hausfater P; Amin D; Amin A; Huber A; Mueller B; Schuetz P
BMJ Open; 2019 Jan; 9(1):e024636. PubMed ID: 30782737
[TBL] [Abstract][Full Text] [Related]
4. Does mid-regional pro-adrenomedullin (MR-proADM) improve the sequential organ failure assessment-score (SOFA score) for mortality-prediction in patients with acute infections? Results of a prospective observational study.
Haag E; Gregoriano C; Molitor A; Kloter M; Kutz A; Mueller B; Schuetz P
Clin Chem Lab Med; 2021 May; 59(6):1165-1176. PubMed ID: 33554514
[TBL] [Abstract][Full Text] [Related]
5. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
Travaglino F; De Berardinis B; Magrini L; Bongiovanni C; Candelli M; Silveri NG; Legramante J; Galante A; Salerno G; Cardelli P; Di Somma S
BMC Infect Dis; 2012 Aug; 12():184. PubMed ID: 22874067
[TBL] [Abstract][Full Text] [Related]
6. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.
Nickel CH; Messmer AS; Geigy N; Misch F; Mueller B; Dusemund F; Hertel S; Hartmann O; Giersdorf S; Bingisser R
Acad Emerg Med; 2013 Jul; 20(7):670-9. PubMed ID: 23859580
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
[TBL] [Abstract][Full Text] [Related]
8. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
[TBL] [Abstract][Full Text] [Related]
9. Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection.
Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; Delfos NM; Leyten EMS; Koster T; Ablij HC; Van't Wout JJW; van Dissel JT
J Infect; 2018 Jul; 77(1):18-24. PubMed ID: 29807091
[TBL] [Abstract][Full Text] [Related]
10. Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia.
Renaud B; Schuetz P; Claessens YE; Labarère J; Albrich W; Mueller B
Chest; 2012 Dec; 142(6):1447-1454. PubMed ID: 22661450
[TBL] [Abstract][Full Text] [Related]
11. Midregional proadrenomedullin safely reduces hospitalization in a low severity cohort with infections in the ED: a randomized controlled multi-centre interventional pilot study.
Gonzalez Del Castillo J; Clemente-Callejo C; Llopis F; Irimia A; Oltra-Hostalet F; Rechner C; Schwabe A; Fernandez-Rodriguez V; Sánchez-Mora C; Giol-Amich J; Prieto-García B; Bardés-Robles I; Ortega-de Heredia MD; García-Lamberechts EJ; Navarro-Bustos C;
Eur J Intern Med; 2021 Jun; 88():104-113. PubMed ID: 33906810
[TBL] [Abstract][Full Text] [Related]
12. Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study.
Dres M; Hausfater P; Foissac F; Bernard M; Joly LM; Sebbane M; Philippon AL; Gil-Jardiné C; Schmidt J; Maignan M; Treluyer JM; Roche N
Int J Chron Obstruct Pulmon Dis; 2017; 12():1047-1056. PubMed ID: 28408815
[TBL] [Abstract][Full Text] [Related]
13. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.
Saeed K; Wilson DC; Bloos F; Schuetz P; van der Does Y; Melander O; Hausfater P; Legramante JM; Claessens YE; Amin D; Rosenqvist M; White G; Mueller B; Limper M; Callejo CC; Brandi A; Macchi MA; Cortes N; Kutz A; Patka P; Yañez MC; Bernardini S; Beau N; Dryden M; van Gorp ECM; Minieri M; Chan L; Rood PPM; Del Castillo JG
Crit Care; 2019 Feb; 23(1):40. PubMed ID: 30736862
[TBL] [Abstract][Full Text] [Related]
14. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.
Gregoriano C; Koch D; Kutz A; Haubitz S; Conen A; Bernasconi L; Hammerer-Lercher A; Saeed K; Mueller B; Schuetz P
Clin Chem Lab Med; 2021 Apr; 59(5):995-1004. PubMed ID: 33554516
[TBL] [Abstract][Full Text] [Related]
15. Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections.
Albrich WC; Rüegger K; Dusemund F; Bossart R; Regez K; Schild U; Conca A; Schuetz P; Sigrist T; Huber A; Reutlinger B; Müller B
Swiss Med Wkly; 2011; 141():w13237. PubMed ID: 21805408
[TBL] [Abstract][Full Text] [Related]
16. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
17. Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department.
Saeed K; Legramante JM; Angeletti S; Curcio F; Miguens I; Poole S; Tascini C; Sozio E; Del Castillo JG
Expert Rev Mol Diagn; 2021 Apr; 21(4):397-404. PubMed ID: 33736553
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin for Risk Stratification of Emergency Patients With Nonspecific Complaints: An Interventional Multicenter Pilot Study.
Nickel CH; Messmer AS; Ghanim L; Ilsemann-Karakoumis J; Giersdorf S; Hertel S; Ernst S; Geigy N; Bingisser R
Medicine (Baltimore); 2016 Jan; 95(1):e2395. PubMed ID: 26735540
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.
Liu D; Xie L; Zhao H; Liu X; Cao J
BMC Infect Dis; 2016 May; 16():232. PubMed ID: 27230573
[TBL] [Abstract][Full Text] [Related]
20. Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.
Haaf P; Twerenbold R; Reichlin T; Faoro J; Reiter M; Meune C; Steuer S; Bassetti S; Ziller R; Balmelli C; Campodarve I; Zellweger C; Kilchenmann A; Irfan A; Papassotiriou J; Drexler B; Mueller C
Int J Cardiol; 2013 Sep; 168(2):1048-55. PubMed ID: 23199555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
